C

플라즈맵

405000KOSDAQ의료용 기기 제조업

43.7 / 100

Reference Date: 2026-04-13

Financial Score7.0 / 40
News Sentiment16.7 / 25
Momentum8.0 / 20
Disclosure12.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Slightly down 3.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Plazmap is a plasma technology company founded in 2015 by KAIST alumni, specializing in bio-plasma applications for the medical device market. Key products include STERLINK (a low-temperature sterilizer using biological inactivation), ACTILINK (a surface activation device for implants using regenerative activation), and CARELINK (a stimulative therapy device for periodontal treatment). The company has achieved global market expansion, including FDA certification in the U.S.

Number of Employees

46people

Average Salary

63.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 26.524.0Point
PBR
4.95Industry Average 1.700.0Point

2.9x industry avg (risky)

ROE
-128.57Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
34.27Industry Average 10.950.0Point

3.1x industry avg (risky)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼18.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲35.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -224.6% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 2Neutral 0Negative 0Average Sentiment Score 75

Detailed Momentum

52-week position3.0Point

52w lower range (27%)

Current 7,380Won52-week high 13,18052-week low 5,200
1-month return2.0Point

1m -3.66% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

8 totalPositive 1Neutral 7Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-04-03
  • Positive단일판매ㆍ공급계약체결2026-03-31
  • Neutral주식매수선택권부여에관한신고2026-03-27
  • Neutral정기주주총회결과2026-03-27
  • Neutral본점소재지변경2026-03-27